EU devices industry disadvantaged in rare disease niche
This article was originally published in Clinica
Executive Summary
Eucomed, the European medical devices industry association, has highlighted the fact that the EU medical devices sector does not benefit from the same incentives as the pharmaceutical sector in terms of investment programmes for products aimed at diagnosing and treating rare diseases, nor as the medical devices industry in the US. The result of this is that patients in the EU whose rare conditions can only be effectively treated with medical devices are being discriminated against compared with those whose rare conditions can be treated with pharmaceuticals or who are being treated in the US.